ReviewOrphanet journal of rare diseases2026
Clinical and genetic characteristics of and diagnostic insights on KBG syndrome in Chinese patients: a retrospective study and literature review.
Review in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMost published cohorts of individuals with KBG are Caucasian which limits the understanding of the genetic diversity and clinical presentation across ethnicities. Herein, we report Chinese patients with KBGS, summarise their clinical and genetic characteristics, and compare their characteristics with those of non-Chinese patients. We retrospectively analysed the data of 65 Chinese patients, identified 33 previously unreported cases, and compared their data with those of 519 non-Chinese patients.
resultsWe noted the most prevalent features in Chinese patients. Large and/or prominent ears, triangular faces, anteverted nares, synophrys, long philtrum, low hairline, spinal anomalies, and recurrent otitis media differed significantly among ethnicities. Among the 51 patients with the c.1903_1907del variant, there were differences across ethnicities; the c.1903_1907del and non-c.1903_1907del variants differed among Chinese patients. Rare phenotypes were identified in Chinese patients. The incidence of IUGR, polyhydramnios, abnormal renal and brain morphology, abnormal cardiovascular system morphology, preterm birth, and higher NT was higher in all patients. Genetic sequencing revealed 14 unreported variants. Eight patients were treated with recombinant human growth hormone and had increased height without significant adverse effects.
conclusionsOur findings support the consideration of KBGS in the differential diagnosis when specific prenatal features (such as IUGR and polyhydramnios) are present. In such scenarios, referral for genetic counseling to discuss the option of testing for ANKRD11 variants and 16q24.3 microdeletions is a prudent clinical step.Overall, Chinese patients with KBGS appear to tolerate growth hormone treatment, but further studies are needed to confirm its long-term safety and efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.